-
Mashup Score: 1Factor XIII subunits are stronger together - 3 month(s) ago
In this issue of Blood, Byrnes and colleagues discuss an elegant series of experiments, in both mice and humans, to explore how the subunits of factor XIII (FXI
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12Brigham and Women's Hospital hiring Hemophilia/ Bleeding Disorder Nurse in Boston, Massachusetts, United States | LinkedIn - 5 month(s) ago
Posted 10:53:05 PM. STAFF NURSE/ HEMOPHILIA/ BLEEDING DISORDER/ FULL TIME 40 HOURS/ BOSTON BWHPosition SummaryThe…See this and similar jobs on LinkedIn.
Source: www.linkedin.comCategories: General Medicine News, Hem/OncsTweet-
Any #nurses with interest in #hemophilia and inherited bleeding disorders? We are hiring @BrighamWomens! Looking for an RN with hematology experience to join my team and serve as a clinical navigator and educator for this unique patient population. https://t.co/Buf1hEJulm
-
-
Mashup Score: 17Museum of Ice Cream to open in Boston - 6 month(s) ago
There’s a new destination for ice cream lovers opening in the Seaport.
Source: www.cbsnews.comCategories: General Medicine News, Hem/OncsTweet-
Sounds like I might have a new way to entice @acweyand to visit me! 🍨 https://t.co/90FTc0rKOp
-
-
Mashup Score: 8
This study sought to examine the frequency and hemodynamic correlates of shortness of breath when bending forward, a symptom we have termed “bendopnea…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet-
I recently learned that bendopnea is an actual term used by cardiologists, and I cannot stop smiling about how amazing it is to describe the phenomenon of shortness of breath after bending over @JAAlvarezMD https://t.co/ZNJL9j8zGQ
-
-
Mashup Score: 1Systems-based hematology: highlighting successes and next steps - 6 month(s) ago
Abstract. Systems-based hematology is dedicated to improving care delivery for patients with blood disorders. First defined by the American Society of Hematolog
Source: ashpublications.orgCategories: General Medicine News, Hematologists1Tweet-
Read more about successes and next steps in systems-based hematology in @BloodAdvances https://t.co/DGpy3TGWHE
-
-
Mashup Score: 4Effects of PK‐guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A - 8 month(s) ago
Introduction In recent years, there has been increased focus on individualizing treatment for persons with hemophilia including pharmacokinetic-guided (PK) dosing. Aims In this retrospective study…
Source: onlinelibrary.wiley.comCategories: Hematologists1, Latest HeadlinesTweet-
This is an interesting retrospective study for patients still using factor VIII products for prophylaxis in moderate or severe hemophilia A. Most using PK-guided prophylaxis schedules had a decrease in ABR or stayed the same. #haemophilia #outcomesresearch https://t.co/71xm8G0jzl
-
-
Mashup Score: 1How I treat erythropoietic protoporphyria and X-linked protoporphyria - 10 month(s) ago
The pathophysiology of erythropoietic protoporphyria and other protoporphyrias is based on disordered heme synthesis, porphyrin transport, and their effects on
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
One of the amazing things in heme is that almost everything we treat is exceedingly rare. I know the basics of porphyria, but I refer anyone with suspected porphyria to my @MassGenBrigham colleague @Rsk2003. Congrats on this outstanding review article! https://t.co/g7oCFqcaKE https://t.co/ndVhasoD9H
-
-
Mashup Score: 9Statement on a Strong Blood Supply - Hematology.org - 12 month(s) ago
Statement on a Strong Blood Supply
Source: www.hematology.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
I'm proud to have led the @ASH_hematology working group that met with stakeholders, crafted the Society's Policy Statement on a Strong Blood Supply (https://t.co/335Fpg1U03), and advocated for an individualized risk-based assessment that @US_FDA recommended today.🩸🏳️🌈 https://t.co/kNgqUghglV
-
-
Mashup Score: 0Delayed normalization of ADAMTS13 activity in acute thrombotic thrombocytopenic purpura in the caplacizumab era - 12 month(s) ago
Key Points. Twenty-eight percent of patients treated with caplacizumab had persistent ADAMTS13 activity <30% within 30 + 28 days after PEX.In patients with A
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
An interesting study in @BloodJournal shows that ADAMTS13 activity recovery is often delayed after TTP is treated with caplacizumab. Underscores the importance of serially measuring ADAMTS13 activity during the treatment phase to avoid relapse. https://t.co/2mgAvKoUXc
-
-
Mashup Score: 1Support Services Job Fair - 12 month(s) ago
Interviewing for:Description – Please note that public transportation does not service the hospital on Sundays so alternate transportation is required for Sunday shifts. Position includes: Assembling, delivering, and retrieving patient meal trays Working in the dishroom Cleaning floors and equipment Restocking work stations and light food preparation. Qualifications High School…
Source: intsignup.indeed.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @FaulknerHosp: Join us next week on May 10 for a support services job fair! More details here: https://t.co/diqvkHg2PE https://t.co/h4Tb…
-
Thank you to @BloodJournal for publishing my Inside Blood commentary about the paper! https://t.co/kK3X0r8uAJ